Reversible Inhibitors of MAO-A (RIMAs)

As for MAOIs, RIMAs inhibit of one of the enzymes that degrades and thereby inactivates monoamine neurotransmitters. However, as compared to the MAOIs, RIMAs do not permanently and irreversibly bind to the enzymes. As a result they are much safer and have fewer potential side effects that the MAOIs. Includes medications such as moclobemide (Aurorix).